CREDIT SUISSE AG/ - KINIKSA PHARMACEUTICALS LTD ownership

KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 107 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q1 2021. The put-call ratio across all filers is 1.40 and the average weighting 0.1%.

Quarter-by-quarter ownership
CREDIT SUISSE AG/ ownership history of KINIKSA PHARMACEUTICALS LTD
ValueSharesWeighting
Q3 2023$441,337
+0.3%
25,408
-18.7%
0.00%
Q2 2023$440,070
+64.8%
31,255
+25.9%
0.00%
Q1 2023$267,052
-19.9%
24,819
+11.5%
0.00%
Q4 2022$333,500
+2.9%
22,263
-11.7%
0.00%
Q3 2022$324,000
+90.6%
25,209
+43.6%
0.00%
Q2 2022$170,000
-12.4%
17,555
-10.2%
0.00%
Q1 2022$194,000
-14.2%
19,545
+1.3%
0.00%
Q4 2021$226,000
+27.0%
19,299
+22.5%
0.00%
Q3 2021$178,000
-14.8%
15,757
+5.0%
0.00%
Q2 2021$209,000
-35.1%
15,005
-13.9%
0.00%
Q1 2021$322,000
-65.0%
17,423
-66.6%
0.00%
Q4 2020$921,000
+420.3%
52,159
+351.0%
0.00%
Q3 2020$177,000
-74.0%
11,566
-56.8%
0.00%
Q2 2020$682,000
+163.3%
26,771
+60.1%
0.00%
Q1 2020$259,000
+27.0%
16,719
-9.5%
0.00%
Q4 2019$204,000
+33.3%
18,471
+2.6%
0.00%
Q3 2019$153,00018,0110.00%
Other shareholders
KINIKSA PHARMACEUTICALS LTD shareholders Q1 2021
NameSharesValueWeighting ↓
Opaleye Management Inc. 1,025,000$12,064,0002.56%
GREAT POINT PARTNERS LLC 536,738$6,317,0001.40%
Endurant Capital Management LP 244,125$2,873,0000.69%
HHLR ADVISORS, LTD. 2,920,023$34,369,0000.53%
Integral Health Asset Management, LLC 140,000$1,648,0000.46%
Spearhead Capital Advisors, LLC 235,024$2,766,0000.33%
Jackson Creek Investment Advisors LLC 77,069$907,0000.32%
RICE HALL JAMES & ASSOCIATES, LLC 712,807$8,390,0000.30%
Parkman Healthcare Partners LLC 113,644$1,338,0000.30%
Birchview Capital, LP 30,000$353,0000.23%
View complete list of KINIKSA PHARMACEUTICALS LTD shareholders